NCT02015819 2021-10-20Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade GliomasCity of Hope Medical CenterPhase 1 Completed16 enrolled 16 charts
NCT01172964 2017-11-09A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade GliomasCity of Hope Medical CenterPhase 1 Completed15 enrolled